Events

4th India Pharmaceutical Forum 2019

#
Session 1: Opening Remarks- Dr Letitia Robinson, USFDA
#
Session 1: Opening Remarks- Ms Maria Filancia, EMA
#
Session 1: Opening Remarks- Investigations for Non-Conformities Guideline: Focus on Batch Failure Investigations
#
Session 2: Reflections on Journey So Far- Mr Vikas Bhadoria, McKinsey & Co
#
Session 2: Building Quality Culture and Capabilities- Dr Jaidev Rajpal, McKinsey & Co
#
Session 2: Experience of Dr Reddy's- Mr Jiwan Goyal, Dr Reddy's
#
Session 3: Concept of Operations and How it May Impact Inspections, Review and Approval- Dr Yuexia Li, PAREXEL Consulting
#
Session 4: How to Build and Maintain an Effective Pharmaceutical Quality Management System- Dr Ajaz Hussain, NIPTE
#
Session 5: Driving Sustainable Cultural transformation- Mr David Churchward, MHRA
#
Session 6: Implications of Brexit for Pharamceutical Industry- Mr David Churchward, MHRA
#
Session 6: Regulatory Update on GMP, Safety Features Regulation and Brexit- Ms Maria Filancia, EMA
#
Session 7: The Valsartan Incident and Lessons Learnt- Ms Hélène Bruguera, EDQM
#
Session 8: Creating Platform for Entry Level Training for Quality Culture: Challenges and Outcomes- Mr Rahul Guha, Boston Consulting Group, India
#
Session 8: Best Practices, Metrics and Symbolic Actions- Mr Vivek Arora, McKinsey & Co
#
Session 8: Experience of Sun Pharmaceutical- Ms Jila Breeze, Sun Pharmaceutical
#
Session 9: Disruptive Technologies in Pharma Operations- Mr Parag Patel, McKinsey & Co
#
Session : Experience of Transformation of Culture with respect to Quality – Experience Sharing by Companies